Soosan Cebotics Co., Ltd. (KRX:017550)
South Korea · Delayed Price · Currency is KRW 2,700.00
+620.00 (29.81%)
At close: Apr 8, 2026
Soosan Cebotics Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 229,388 | 197,892 | 226,541 | 286,297 | 252,992 |
Other Revenue | -0 | - | - | - | -0 |
| 229,388 | 197,892 | 226,541 | 286,297 | 252,992 | |
Revenue Growth (YoY) | 15.92% | -12.65% | -20.87% | 13.16% | 83.55% |
Cost of Revenue | 174,296 | 149,676 | 174,245 | 222,157 | 204,193 |
Gross Profit | 55,092 | 48,216 | 52,296 | 64,140 | 48,799 |
Selling, General & Admin | 27,755 | 26,942 | 28,006 | 34,028 | 27,133 |
Research & Development | 4,772 | 4,869 | 4,804 | 4,819 | 3,660 |
Amortization of Goodwill & Intangibles | 1,678 | 1,053 | 1,129 | 1,181 | 1,392 |
Other Operating Expenses | 685.05 | 652.99 | 691.39 | 668.94 | 529.15 |
Operating Expenses | 36,080 | 36,128 | 35,716 | 41,580 | 34,607 |
Operating Income | 19,012 | 12,088 | 16,580 | 22,559 | 14,192 |
Interest Expense | -1,147 | -2,171 | -3,357 | -2,722 | -2,026 |
Interest & Investment Income | 879.97 | 1,162 | 936.53 | 493.65 | 502.57 |
Earnings From Equity Investments | - | - | 3,247 | - | - |
Currency Exchange Gain (Loss) | -311.52 | 2,607 | 1,609 | 806.59 | 2,742 |
Other Non Operating Income (Expenses) | 201.46 | -1,047 | 378.36 | 333.15 | 4.49 |
EBT Excluding Unusual Items | 18,634 | 12,638 | 19,393 | 21,470 | 15,416 |
Gain (Loss) on Sale of Investments | 5.54 | -5.54 | 4.04 | -0.24 | -11.59 |
Gain (Loss) on Sale of Assets | 26.74 | 46.66 | -116.68 | 10.07 | 758.06 |
Asset Writedown | -6.08 | 6.91 | -95.09 | -1,213 | -1,988 |
Pretax Income | 18,661 | 12,686 | 19,186 | 20,268 | 14,175 |
Income Tax Expense | 2,820 | 3,460 | 2,313 | 4,518 | 2,781 |
Earnings From Continuing Operations | 15,840 | 9,226 | 16,873 | 15,749 | 11,393 |
Net Income | 15,840 | 9,226 | 16,873 | 15,749 | 11,393 |
Net Income to Common | 15,840 | 9,226 | 16,873 | 15,749 | 11,393 |
Net Income Growth | 71.69% | -45.32% | 7.13% | 38.23% | 182.59% |
Shares Outstanding (Basic) | 62 | 62 | 57 | 54 | 54 |
Shares Outstanding (Diluted) | 62 | 62 | 57 | 54 | 54 |
Shares Change (YoY) | 0.04% | 10.07% | 4.96% | 0.05% | 4.83% |
EPS (Basic) | 254.00 | 148.00 | 297.92 | 291.88 | 211.25 |
EPS (Diluted) | 254.00 | 148.00 | 297.92 | 291.88 | 211.25 |
EPS Growth | 71.62% | -50.32% | 2.07% | 38.16% | 169.55% |
Free Cash Flow | -1,925 | 17,213 | 9,613 | -7,855 | -7,984 |
Free Cash Flow Per Share | -30.87 | 276.13 | 169.73 | -145.57 | -148.04 |
Gross Margin | 24.02% | 24.37% | 23.09% | 22.40% | 19.29% |
Operating Margin | 8.29% | 6.11% | 7.32% | 7.88% | 5.61% |
Profit Margin | 6.91% | 4.66% | 7.45% | 5.50% | 4.50% |
Free Cash Flow Margin | -0.84% | 8.70% | 4.24% | -2.74% | -3.16% |
EBITDA | 25,099 | 17,221 | 21,385 | 27,493 | 19,136 |
EBITDA Margin | 10.94% | 8.70% | 9.44% | 9.60% | 7.56% |
D&A For EBITDA | 6,087 | 5,132 | 4,805 | 4,934 | 4,944 |
EBIT | 19,012 | 12,088 | 16,580 | 22,559 | 14,192 |
EBIT Margin | 8.29% | 6.11% | 7.32% | 7.88% | 5.61% |
Effective Tax Rate | 15.11% | 27.27% | 12.05% | 22.29% | 19.62% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.